ESMO Open

SJR Rank #567H-index: 81SJR: 3.455Best quartile: Q1Open AccessAPC: US$3,910Listed in DOAJ
Journal website: aims, scope and author guidelines
Publisher

Elsevier B.V.

Country

United Kingdom

Type

journal

SJR by Edition

2022202500.91.82.73.6

Subject Categories

  • Cancer ResearchQ1
  • OncologyQ1

Areas: Biochemistry, Genetics and Molecular Biology · Medicine

Most published research topics

Cancer Immunotherapy and BiomarkersLung Cancer Treatments and MutationsAdvanced Breast Cancer TherapiesBreast Cancer Treatment StudiesHER2/EGFR in Cancer ResearchCancer Genomics and DiagnosticsLung Cancer Research StudiesCancer Treatment and PharmacologyColorectal Cancer Treatments and StudiesPARP inhibition in cancer therapy

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs0200400600800

Documents per Year

20222025095190285380

Detailed Information

ISSN

2059-7029

SJR Best Quartile

Q1

Region

Western Europe

Citations per Document (2 years)

7.59

References per Document

32.88

Coverage

2016-2026

Scope

he journal aims to publish research in all disciplines, experimental, translational, diagnostic and therapeutic areas related to oncology, including: original articles, reviews, editorials and correspondence. In addition the journal welcomes phase I trials and meta-analyses, and will also publish reviews from important European Society for Medical Oncology (ESMO) conferences and meetings as well as position statements on behalf of ESMO. ESMO Open aims to operate a fast submission process with continuous publication online, to ensure that timely, up-to-date research is available worldwide and adheres to a rigorous and transparent peer review process. ESMO Open adheres to the highest possible industry standards concerning publication ethics With the widest possible reach and an international editorial board of experts and key opinion leaders, the journal aims to rapidly disseminate the best in innovative clinical and translational cancer research and improve the quality of education, prevention, diagnosis, treatment and patient care worldwide.

Metrics from SCImago Journal Rank 2025. View on SCImago